Clarithromycin For Improved Clinical Outcomes in Community-Acquired Pneumonia: A Subgroup Analysis of the ACCESS Study

•ACCESS trial showed early anti-inflammatory effect of clarithromycin in hospitalized adults with CAP•Subgroups of patients differentiated by metrics were examined•The primary endpoint integrated respiratory symptoms, SOFA score and procalcitonin•Need for mechanical ventilation was analyzed•Benefit...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	International journal of antimicrobial agents 2024-12, p.107406, Article 107406
Hauptverfasser:	Akinosoglou, Karolina, Leventogiannis, Konstantinos, Tasouli, Elisavet, Kakavoulis, Nikolaos, Niotis, Georgios, Doulou, Sarantia, Skorda, Lamprini, Iliopoulou, Konstantina, Papailiou, Anna, Katsaounou, Paraskevi, Rapti, Vassiliki, Chrysos, George, Seferlis, Theodoros, Gerakari, Styliani, Dakou, Konstantina, Papanikolaou, Ilias C., Milionis, Haralampos, Kewitz, Samantha, Georgiadou, Sara, Kontopoulou, Theano, Tzavara, Vasiliki, Torres, Antonio, Niederman, Michael S., Giamarellos-Bourboulis, Evangelos J.
Format:	Artikel
Sprache:	eng
Schlagworte:	clarithromycin early response inflammation pneumonia
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!